Original Research
Accepted on 16 Feb 2026
Dermatological and gastrointestinal adverse reactions in ocrelizumab treated patients with multiple sclerosis: a case series
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 16 Feb 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 16 Feb 2026
in Aging and Public Health
Original Research
Accepted on 16 Feb 2026
in Health Communications and Behavior Change
Mini Review
Accepted on 16 Feb 2026
in Pediatric Neurology
Original Research
Accepted on 16 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 16 Feb 2026
in Educational Psychology
Original Research
Accepted on 16 Feb 2026
in Social and Emotional Development
Original Research
Accepted on 16 Feb 2026
in Hepatobiliary Diseases
Original Research
Accepted on 16 Feb 2026
in Quaternary Science, Geomorphology and Paleoenvironment
Original Research
Accepted on 16 Feb 2026
in Elite Sports and Performance Enhancement
Case Report
Accepted on 16 Feb 2026
in Disaster Medicine
Original Research
Accepted on 16 Feb 2026
in Ocean Observation
Original Research
Accepted on 16 Feb 2026
in Maternal Health
Study Protocol
Accepted on 16 Feb 2026
in Intensive Care Medicine and Anesthesiology
Original Research
Accepted on 16 Feb 2026
in Speech and Language
Original Research
Accepted on 16 Feb 2026
in Ocean Observation